Clinical Trial Update: Secondary Adult's Hemophagocytic Lymphohistiocytosis and Innate Immunity [NA]

View source ↗

Summary

The clinical trial NCT01125319 studying secondary adult-onset hemophagocytic lymphohistiocytosis and innate immunity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Hemophagocytic Lymphohisticytosis | NA | Status: COMPLETED